Pacira BioSciences, Inc. Common Stock (PCRX) is a publicly traded Healthcare sector company. As of September 9, 2026, PCRX trades at $25.75 with a market cap of $1.05B and a P/E ratio of 73.78. PCRX moved -0.46% today. Year to date, PCRX is -0.04%; over the trailing twelve months it is -3.25%. Its 52-week range spans $18.80 to $27.66. Analyst consensus is buy with an average price target of $28.80. Rallies surfaces PCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PCRX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $25.75 |
| Market Cap | $1.05B |
| P/E Ratio | 73.78 |
| EPS | $0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.66 |
| 52-Week Low | $18.80 |
| Volume | 2.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $746.16M |
| Net Income | $14.64M |
| Gross Margin | 79.21% |
6 analysts cover PCRX: 0 strong buy, 3 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $28.80.